| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
|
de Boer, Stephanie M
|
|
|
19 |
3 |
p. 295-309
|
artikel
|
| 2 |
Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancer
|
Rosell, Rafael
|
|
|
19 |
3 |
p. e126
|
artikel
|
| 3 |
Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancer
|
Wu, Fang
|
|
|
19 |
3 |
p. e124
|
artikel
|
| 4 |
Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancer
|
Ma, Jin-an
|
|
|
19 |
3 |
p. e125
|
artikel
|
| 5 |
Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancer – Authors' reply
|
Wu, Yi-Long
|
|
|
19 |
3 |
p. e127
|
artikel
|
| 6 |
Adjuvant therapy for women with high-risk endometrial carcinoma
|
Dowdy, Sean C
|
|
|
19 |
3 |
p. 268-269
|
artikel
|
| 7 |
Apalutamide shows efficacy in prostate cancer
|
Gourd, Elizabeth
|
|
|
19 |
3 |
p. e149
|
artikel
|
| 8 |
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
|
McQuade, Jennifer L
|
|
|
19 |
3 |
p. 310-322
|
artikel
|
| 9 |
A start towards immunotherapy in sarcomas?
|
Hohenberger, Peter
|
|
|
19 |
3 |
p. 283-285
|
artikel
|
| 10 |
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
|
Atkins, Michael B
|
|
|
19 |
3 |
p. 405-415
|
artikel
|
| 11 |
BMI and outcomes in melanoma: more evidence for the obesity paradox
|
Hayes, Andrew J
|
|
|
19 |
3 |
p. 269-270
|
artikel
|
| 12 |
Cancer control in war-torn Iraq
|
Alwan, Nada
|
|
|
19 |
3 |
p. 291-292
|
artikel
|
| 13 |
Cancer diagnosis distress eased through online intervention
|
Gourd, Elizabeth
|
|
|
19 |
3 |
p. e142
|
artikel
|
| 14 |
Cancer groundshot: going global before going to the moon
|
Gyawali, Bishal
|
|
|
19 |
3 |
p. 288-290
|
artikel
|
| 15 |
Cancer in pregnancy: evidence, or still empiricism?
|
Köhler, Christhardt
|
|
|
19 |
3 |
p. 272-274
|
artikel
|
| 16 |
Cancer-related productivity losses in BRICS countries
|
Venkatesan, Priya
|
|
|
19 |
3 |
p. e147
|
artikel
|
| 17 |
CAR T-cells for relapsed B-cell ALL in adults
|
Gilbert, Judith A
|
|
|
19 |
3 |
p. e143
|
artikel
|
| 18 |
CAR T-cells for relapsed B-cell ALL in children and young adults
|
Stirrups, Robert
|
|
|
19 |
3 |
p. e144
|
artikel
|
| 19 |
Chromatin organisation and cancer prognosis: a pan-cancer study
|
Kleppe, Andreas
|
|
|
19 |
3 |
p. 356-369
|
artikel
|
| 20 |
Clinical trials in older, less fit populations: an unmet need?
|
Geyer Jr, Charles E
|
|
|
19 |
3 |
p. 271-272
|
artikel
|
| 21 |
Collaborative action will generate better outcomes
|
Corry, June
|
|
|
19 |
3 |
p. 278-280
|
artikel
|
| 22 |
Combination therapies for patients with metastatic renal cell carcinoma
|
Procopio, Giuseppe
|
|
|
19 |
3 |
p. 281-283
|
artikel
|
| 23 |
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease
|
ter Veer, Emil
|
|
|
19 |
3 |
p. e151-e160
|
artikel
|
| 24 |
Correction to Lancet Oncol 2018; 19: 87–100
|
|
|
|
19 |
3 |
p. e137
|
artikel
|
| 25 |
Correction to Lancet Oncol 2018; 19: 257–66
|
|
|
|
19 |
3 |
p. e137
|
artikel
|
| 26 |
Correction to Lancet Oncol 2017; 18: e354–63
|
|
|
|
19 |
3 |
p. e137
|
artikel
|
| 27 |
Denosumab for myeloma bone disease: ready for prime time?
|
Dimopoulos, Meletios A
|
|
|
19 |
3 |
p. 277-278
|
artikel
|
| 28 |
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study
|
Raje, Noopur
|
|
|
19 |
3 |
p. 370-381
|
artikel
|
| 29 |
Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study
|
Tang, Xin-Ran
|
|
|
19 |
3 |
p. 382-393
|
artikel
|
| 30 |
Early integration of palliative care—new evidence and old questions
|
Kaasa, Stein
|
|
|
19 |
3 |
p. 280-281
|
artikel
|
| 31 |
Effect of early and systematic integration of palliative care in patients with advanced cancer: a randomised controlled trial
|
Vanbutsele, Gaëlle
|
|
|
19 |
3 |
p. 394-404
|
artikel
|
| 32 |
HIPEC improves survival in stage III epithelial ovarian cancer
|
Stirrups, Robert
|
|
|
19 |
3 |
p. e138
|
artikel
|
| 33 |
Immune checkpoint inhibitors: the next step for thymic carcinomas
|
Okuma, Yusuke
|
|
|
19 |
3 |
p. 274-275
|
artikel
|
| 34 |
Large parapharyngeal mass: a challenging differential diagnosis
|
Ralli, Massimo
|
|
|
19 |
3 |
p. e181
|
artikel
|
| 35 |
Low-dose CT for lung cancer screening
|
Bach, Peter B
|
|
|
19 |
3 |
p. e133-e134
|
artikel
|
| 36 |
Low-dose CT for lung cancer screening
|
Ruano-Ravina, Alberto
|
|
|
19 |
3 |
p. e131-e132
|
artikel
|
| 37 |
Low-dose CT for lung cancer screening – Authors' reply
|
Field, John K
|
|
|
19 |
3 |
p. e135-e136
|
artikel
|
| 38 |
MSM in England to be offered free HPV vaccination
|
Kirby, Tony
|
|
|
19 |
3 |
p. e148
|
artikel
|
| 39 |
Neoadjuvant chemotherapy for early breast cancer
|
Krug, David
|
|
|
19 |
3 |
p. e129
|
artikel
|
| 40 |
Neoadjuvant chemotherapy for early breast cancer
|
Charalampoudis, Petros
|
|
|
19 |
3 |
p. e128
|
artikel
|
| 41 |
Neoadjuvant chemotherapy for early breast cancer – Author's reply
|
McGale, Paul
|
|
|
19 |
3 |
p. e130
|
artikel
|
| 42 |
New cancer blood test developed
|
Burki, Talha Khan
|
|
|
19 |
3 |
p. e140
|
artikel
|
| 43 |
Next-generation nuclear morphology to grade solid tumours
|
Kristiansen, Glen
|
|
|
19 |
3 |
p. 275-277
|
artikel
|
| 44 |
Nivolumab plus ipilimumab in metastatic colorectal cancer
|
Gourd, Elizabeth
|
|
|
19 |
3 |
p. e139
|
artikel
|
| 45 |
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials
|
D'Angelo, Sandra P
|
|
|
19 |
3 |
p. 416-426
|
artikel
|
| 46 |
Novel therapies for malignant pleural mesothelioma
|
Scherpereel, Arnaud
|
|
|
19 |
3 |
p. e161-e172
|
artikel
|
| 47 |
Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients
|
de Haan, Jorine
|
|
|
19 |
3 |
p. 337-346
|
artikel
|
| 48 |
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
|
Giaccone, Giuseppe
|
|
|
19 |
3 |
p. 347-355
|
artikel
|
| 49 |
Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group
|
Wildiers, Hans
|
|
|
19 |
3 |
p. 323-336
|
artikel
|
| 50 |
Public Health England publishes e-cigarette review
|
Burki, Talha Khan
|
|
|
19 |
3 |
p. e150
|
artikel
|
| 51 |
Selinexor and dexamethasone in multiple myeloma
|
Burki, Talha Khan
|
|
|
19 |
3 |
p. e146
|
artikel
|
| 52 |
Source of stem cells in haploidentical transplantation
|
Das, Manjulika
|
|
|
19 |
3 |
p. e141
|
artikel
|
| 53 |
The evolution of anticancer drug discovery from plants
|
Howes, Melanie-Jayne R
|
|
|
19 |
3 |
p. 293-294
|
artikel
|
| 54 |
Tumour-treating fields complement glioblastoma treatment
|
Gourd, Elizabeth
|
|
|
19 |
3 |
p. e145
|
artikel
|
| 55 |
UK National Health Service—beyond repair?
|
The Lancet Oncology,
|
|
|
19 |
3 |
p. 267
|
artikel
|
| 56 |
Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative
|
Dirven, Linda
|
|
|
19 |
3 |
p. e173-e180
|
artikel
|
| 57 |
10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers
|
Pearson, Andrew DJ
|
|
|
19 |
3 |
p. 285-287
|
artikel
|
Tijdschrift beschrijving